// App-Quantinova.ai

11012 : Prognostic impact of changes in circulating tumor cells (CTC) in metastatic breast cancer (MBC).

Researchers

Presenter

  • Markus Wallwiener

Principal Investigators

  • Andreas D. Hartkopf

  • Sabine Riethdorf

  • Joerg Heil

  • Christof Sohn

  • Klaus Pantel

  • Andreas Trumpp

  • Andreas Schneeweiss

  • Martin Sprick

  • Christoph Wolfram Domschke

  • Sarah Schott

  • Irene Baccelli

  • Caroline Modugno

  • Birgitt Schoenfisch

  • Barbara Burwinkel

  • Frederik Marme

Medical Centers

  • Department of Obstetrics and Gynecology, Bergen, Norway

  • Department of Molecular Epidemiology, German Cancer Research Center, and Department of Obstetrics and Gynecology, University Hospital of Heidelberg, Heidelberg, Germany

  • DKFZ German Cancer Research Centre, Heidelberg Institute for Stem Cell Technology and Experimental Medicine, Heidelberg, Germany

  • Department of Obstetrics and Gynaecology, University of Heidelberg,, Heidelberg, Germany

  • University Clinic Heidelberg, Heidelberg, Germany

  • II. Medical Clinic & Institute of Tumor Biology, Campus Forschung, University Hospital Hamburg-Eppendorf, Hamburg, Germany

  • Department of Obstetrics and Gynaecology, University of Heidelberg,, Heidelberg, Germany

  • Department of Obstetrics and Gynaecology, University of Heidelberg,, Heidelberg, Germany

  • National Center for Tumor Diseases DKFZ, Heidelberg, Germany

  • Department of Gynecology and Obstetrics within the National Centre of Tumor Disease, University of Heidelberg, Heidelberg, Germany

  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • S-295/2009

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved